Result of AGM

This reads as low-signal governance housekeeping rather than a fundamental catalyst. The only economically meaningful lever is the investment-policy amendment: if it widens the mandate toward more liquid/higher-beta China exposures, the fund’s factor profile could shift faster than the market notices, but that benefit only matters once the text is published and the portfolio is actually rebalanced. Until then, the stock is still primarily a wrapper around China risk, not a standalone earnings story.

The renewal of issuance authority matters more for the discount/premium equation than for asset growth. For closed-end funds, the same authority can be accretive if used into a premium and dilutive if used while trading at a discount; the market’s reaction should therefore track NAV spread behavior over the next 1-3 months, not the AGM result itself. Contrarian take: investors may be overpricing dilution risk because this is standard flexibility, but the true test is whether management pairs it with buybacks/tenders or simply preserves optionality. Falsifier: a persistent wider discount to NAV without capital-return action, or a policy amendment that proves cosmetic rather than expansive.